abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

Esta página não está disponível em Português e está sendo exibida em English

Ação judicial

29 Ago 2001

Pfizer lawsuit (re administration of experimental drug in Nigeria, filed in USA)

Status: CLOSED

Data em que a ação judicial foi iniciada
29 Ago 2001
Desconhecido
Crianças
Local de Arquivamento: Estados Unidos da América
Localização do Incidente: Nigéria
Tipo de litígio: Transnacional

Empresas

Pfizer Estados Unidos da América Produtos Farmacêuticos

Fontes

Snapshot: In 2001, a group of Nigerian minors and their guardian sued Pfizer in US court alleging the company violated customary international law by administering an experimental drug to Nigerian minors. In 2011, the parties announced they had reached a settlement in this lawsuit. This case profile looks at proceedings in the US.

In 1996, Pfizer conducted a drug trial in Kano, Nigeria during an epidemic of bacterial meningitis.  The company tested an experimental antibiotic drug, Trovan, on about 200 children during this time.

United States lawsuits
In 2001, a group of Nigerian minors and their guardians sued Pfizer in US federal court under the Alien Tort Claims Act (ATCA) alleging that the company violated customary international law by administering Trovan to minors in Kano during the meningitis outbreak.  The plaintiffs in Abdullahi v. Pfizer claim that the drug was given without the informed consent of the children and their parents.  The plaintiffs further claim that the drug trial led to the deaths of 11 children and serious injuries to many others.  A second US lawsuit was filed against Pfizer, Adamu v. Pfizer, in November 2002.  These plaintiffs were also a group of Nigerians injured in the Trovan drug trial.  The Adamu plaintiffs alleged similar violations under ATCA and violations of Connecticut law.  Both of these cases were dismissed in 2005 on grounds of forum non conveniens (inconvenient forum – information on this legal doctrine available here) and failure to state a claim under ATCA.  According to the judge, the plaintiffs had failed to show a sufficient legal source for an international prohibition of non-consensual medical treatment.

In January 2009, the US court of appeals reversed the lower courts’ dismissal of the case. (The two lawsuits have been consolidated.)  A divided court found that the prohibition of non-consensual medical experimentation on humans is binding under customary international law.  In July 2009, Pfizer petitioned the US Supreme Court asking it to hear an appeal of the Court of Appeals' January 2009 ruling.  In November 2009 the Supreme Court asked the US Solicitor General to submit a brief to the court in this case.  In May 2010 the Solicitor General submitted this brief to the court urging the court to deny Pfizer's petition.

On February 23, 2011, the parties announced that they had reached a settlement in this lawsuit.  The terms of the settlement are confidential.  A joint statement issued by the parties explained that the plaintiffs in the US lawsuit will join the ongoing Healthcare/Meningitis Trust Fund process which is being managed by an independent board of trustees in Kano, Nigeria. 

- "Pfizer pays out to Nigerian families of drug trial victims", David Smith, Guardian [UK], 12 Aug 2011
- "Pfizer Settles Lawsuits Over Drug Trials on Children in Nigeria", Sue Reisinger, Corporate Counsel, 23 Feb 2011
- "Pfizer settles drug testing case with Nigerian state for $75 million", Ross Todd, American Lawyer, 3 Aug 2009
- "Pfizer reaches settlement in notorious Nigerian drug trial", Joe Stephens, Washington Post, 4 Apr 2009
- “Attorney Continues Long Battle With Pfizer Over Nigerian Drug Experiments”, Douglas S. Malan, Connecticut Law Tribune [USA], 12 Feb 2009 
- “Split 2nd Circuit Revives Nigerian Families' Claims Against Pfizer Over Drug Tests”, Daniel Wise, New York Law Journal, 2 Feb 2009 
- “Fed Govt, Pfizer opt for out-of-court settlement”, The Nation [Nigeria], 27 Jan 2009 
- “Pfizer Drug Trial Case In Nigeria To Restart Feb 25”, AFP, 28 Jan 2009
- “Nigeria sues drugs giant Pfizer”, BBC News, 5 Jun 2007 
- “Pfizer faces criminal charges in Nigeria”, Joe Stephens, Washington Post, 30 May 2007

- Pfizer: [PDF] Pfizer responds to divided ruling by U.S. Court of appeals for 2nd circuit in cases related to Trovan study in Nigeria, 30 Jan 2009 
- Pfizer: [PDF] Pfizer issued the following statement in response to legal action taken against the company by the Nigerian government, 29 May 2007

- [PDF] Pfizer Inc. v. Abdullahi, et al. - Brief for the United States as amicus curiae, Solicitor General, US Department of Justice, 30 May 2010
- [PDF] Pfizer Inc. v. Abdullahi, et al. - Reply Brief for Petitioner, Quinn Emanuel Urquhart Oliver & Hedges LLP, 25 Aug 2009
- [PDF] Pfizer Inc. v. Abdullahi, et al. - Brief in Opposition, Altschuler & Altschuler, Milberg LLP, 10 Aug 2009
- [PDF] Pfizer Inc. v. Abdullahi, et al. - Petition for a Writ of Certiorari, Quinn Emanuel Urquhart Oliver & Hedges LLP, 8 jul 2009
- US Court of Appeals for the Second Circuit: [PDF] Rabi Abdullahi v. Pfizer, Inc., 30 Jan 2009 [decision reversing lower court’s dismissals] 
- US District Court for the Southern District of New York: 
     - [PDF] Adamu v. Pfizer, Inc., 8 Nov 2005 [dismissal] 
     - [PDF] Abdullahi v. Pfizer, Inc., 9 Aug 2005 [dismissal]

Linha do tempo